✦ LIBER ✦

Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms

✍ Scribed by Anand, S.; Stedham, F.; Beer, P.; Gudgin, E.; Ortmann, C. A.; Bench, A.; Erber, W.; Green, A. R.; Huntly, B. J. P.

Book ID: 121685514
Publisher: American Society of Hematology
Year: 2011
Tongue: English
Weight: 363 KB
Volume: 118
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2010-12-327593

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

JAK2 allele burden in the myeloprolifera

JAK2 allele burden in the myeloproliferative neoplasms: effects on phenotype, prognosis and change with treatment

✍ Vannucchi, A. M.; Pieri, L.; Guglielmelli, P. 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 164 KB

Absence of the JAK2 exon 12 mutations in

Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms

✍ Alessia Fiorini; Patrizia Chiusolo; Elena Rossi; Tommaso Za; Daniela G. De Ritis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

Detection of the JAK2 mutation in myelop

Detection of the JAK2 mutation in myeloproliferative neoplasms by asymmetric PCR with unlabeled probe and high-resolution melt analysis

✍ Hong-Cui Cao; Jiang Lin; Jun Qian; Dong-Ming Yao; Yun Li; Jing Yang; Qin Chen; H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

## Abstract __Background__: Several methods have been established to detect the JAK2 V617F mutation, a frequent event involved in the pathogenesis of myeloproliferative neoplasms (MPNs). High‐resolution melt (HRM) analysis is a newly established technique without the requirement of any gel‐based po

Update on the impact of the JAK2 mutatio

Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders

✍ Radek Skoda 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Chromosomal abnormalities in transformed

Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations

✍ Florence Nguyen-Khac; Claude Lesty; Virginie Eclache; Lucile Couronné; Olivier K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

## Abstract Evolution to myelofibrosis (MF), acute myeloid leukemia or myelodysplastic syndrome (AML/MDS) may occur over time in myeloproliferative neoplasms (MPN) patients most likely due to the acquisition of additional mutations. The Groupe Francophone de cytogenetique hematologique (GFCH) has c

Clonal analysis of TET2 and JAK2 mutatio

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms

✍ Schaub, F. X.; Looser, R.; Li, S.; Hao-Shen, H.; Lehmann, T.; Tichelli, A.; Skod 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 702 KB